Skip to main content

Table 2 Comparison of patients with and without confirmed pneumonia – all parameters available within 3 days

From: Early pneumonia and timing of antibiotic therapy in patients after nontraumatic out-of-hospital cardiac arrest

 

All patients

No confirmed pneumonia

Confirmed pneumonia

p value

(n = 174)

(n = 135)

(n = 39)

Age (years)

69.0 (57.0–77.0)

68.0 (57.0–76.5)

72.0 (60.0–77.5)

0.303

Sex category = male

135 (77.6 %)

104 of 135 (77.0 %)

31 of 39 (79.5 %)

0.830

Cardiovascular risk factors

 Smoking

65 (37.4 %)

51 of 135 (37.8 %)

14 of 39 (35.9 %)

0.493

 Hypertension

96 (55.2 %)

72 of 135 (53.3 %)

24 of 39 (61.5 %)

0.465

 Diabetes mellitus

39 (22.4 %)

33 of 135 (24.4 %)

6 of 39 (15.4 %)

0.281

 Adipositas

28 (16.1 %)

23 of 135 (17.0 %)

5 of 39 (12.8 %)

0.627

 Known coronary vascular disease

40 (23.0 %)

29 of 135 (21.5 %)

11 of 39 (28.2 %)

0.393

Cardiopulmonary resuscitation

 Free interval (minutes)

5.0 (0.0–10.0)

5.0 (0–10.0)

3.0 (0–10.0)

0.928

 First rhythm

    

  Ventricular tachycardia

3 (1.7 %)

3 of 135 (2.2 %)

0 of 39 (0.0 %)

1.000

  Ventricular fibrillation

113 (64.9 %)

88 of 135 (65.2 %)

25 of 39 (64.1 %)

1.000

  Asystole

34 (19.5 %)

27 of 135 (20.0 %)

7 of 39 (17.9 %)

1.000

  Pulseless electrical activity

17 (9.8 %)

12 of 135 (8.9 %)

5 of 39 (12.8 %)

0.540

  Other or unknown

7 (4.0 %)

5 of 135 (3.7 %)

2 of 39 (5.1 %)

0.654

 Time to ROSC (minutes)

24.5 (15.0–35.0)

25.0 (15.0–35.0)

22.0 (15.5–34.8)

0.666

 Witnessed aspiration

22 (12.6 %)

18 of 135 (13.3 %)

4 of 39 (10.3 %)

0.787

Laboratory values

 CRP (mg/l) on admission (day 1), n = 170

3.0 (2.0–10.4)

3.0 (2.0–8.9)

2.9 (2.0–20.9)

0.915

 CRP (mg/l) on day 2, n = 173

24.0 (8.6–50.7)

23.1 (8.7–48.1)

25.3 (7.0–52.7)

0.943

 CRP (mg/l) on day 3, n = 169

124.1 (89.6–166.0)

124.2 (93.5–159.2)

123.6 (81.6–197.5)

0.896

 WBC (103/μl) on admission (day 1), n = 174

15.5 (10.7–19.1)

15.2 (10.6–18.2)

16.6 (11.2–21.0)

0.237

 WBC (103/μl) day 2, n = 174

12.7 (9.2–17.5)

12.9 (9.6–17.4)

10.3 (9.1–17.1)

0.295

 WBC (103/μl) day 3, n = 170

12.3 (9.1–15.6)

12.5 (9.3–15.9)

11.2 (8.4–14.9)

0.204

 PCT (μg/l) day 1, n = 121a

0.1 (0.1–0.6)

0.1 (0.1–0.5)

0.2 (0.1–1.1)

0.312

 PCT (μg/l) day 2, n = 83a

1.9 (0.5–7.7)

2.0 (0.5–10.2)

1.2 (0.5–2.7)

0.271

 PCT (μg/l) day 3, n = 89a

1.7 (0.5–6–1)

1.6 (0.6–6.1)

3.0 (0.5–6.0)

0.642

 Lactate (mmol/l) on admission, n = 172

3.7 (2.2–6.8)

5.4 (3.3–7.9)

4.7 (3.2–6.6)

0.301

Respiration

 PO2/FiO2 minimum on day 1

152 (100–228)

152 (100–230)

161 (109–211)

0.891

 PO2/FiO2 minimum on day 2

165 (121–222)

160 (117–220)

167 (132–220)

0.502

 PO2/FiO2 minimum on day 3

160 (126–205)

160 (127–206)

155 (128–188)

0.479

 PEEP maximum (mbar) on day 1

8.5 (7.0–11.0)

8.0 (7.0–10.0)

10.0 (8.0–12.0)

0.014

 PEEP maximum (mbar) on day 2

9.0 (7.0–11.0)

8.0 (7.0–10.0)

10.0 (7.5–12.0)

0.114

 PEEP maximum (mbar) on day 3

9.0 (7.0–12.0)

8.0 (7.0–12.0)

9.0 (7.0–11.5)

0.603

Hemodynamics

 Vasopressor dosageb (μg/minute) on day 1

16.0 (8.0–32.0)

16.0 (8.0–30.0)

14.0 (9.5–33.5)

0.712

 Vasopressor dosageb (μg/minute) on day 2

19.0 (10.0–32.0)

20.0 (10.0–32.0)

18.0 (10.0–33.0)

0.983

 Vasopressor dosageb (μg/minute) on day 3

16.0 (9.0–32.0)

16.0 (9.0–32.0)

16.0 (9.5–38.0)

0.941

 Volume infusion (l) on day 1

4.7 (3.1–7.0)

4.5 (3.0–6.9)

5.1 (3.2–7.6)

0.469

 Volume infusion (l) on day 2

7.0 (5.0–9.8)

7.3 (5.3–9.8)

6.8 (4.3–9.3)

0.396

 Volume infusion (l) on day 3

4.5 (3.4–6.4)

4.4 (3.4–6.4)

4.8 (3.9–6.1)

0.347

Infection and antibiotics

 Time to antibiotics (hours)

8.7 (5.4–22.8)

8.5 (5.4–22.4)

9.0 (6.0–26.9)

0.381

 Post-hypothermia fever, n = 135c

75 of 135 (55.6 %)

54 of 101 (53.5 %)

21 of 34 (61.8 %)

0.431

  1. Data presented as absolute numbers (percentages) or median (25th–75th percentile). n refers to the number of patients with available data
  2. We also tested whether or not there was a difference of any of the presented parameters between patients with or without confirmed or probable pneumonia. Data are presented in Additional file 3
  3. aMissing data, because PCT values are not measured routinely every day in our ICU
  4. bIntravenous vasopressors were given in order to maintain a mean arterial pressure (MAD) of >65 mmHg. Norepinephrine was used as vasopressor of first choice; epinephrine was used when a second vasopressor was necessary to maintain MAD. When a second vasopressor was necessary, numbers in the table reflect the dosage of both vasopressors. The number gives the highest dosage used on each day
  5. cMissing data are caused by patients already being dead at this time point
  6. CRP C-reactive protein, PCT procalcitonin PEEP positive end expiratory pressure, ROSC return of spontaneous circulation, WBC white blood cell count, PaO 2 /FiO 2 Partial pressure of oxygen in arterial blood [mmHg] / Fraction of inspired oxygen
  7. For variables that are statistically different betwen patients with and without confirmed pneumonia given p-values are highlighted by bold characters.